Clinical Trial Update: Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen) [Phase 2]

View source ↗

Summary

Phase 2 trial update for cabozantinib in advanced penile squamous cell carcinoma (PSCC) ongoing; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Squamous Cell Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Penile Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN